ArticleCureus2025
Isolated Ophthalmoplegia as an Atypical Manifestation of Miller Fisher Syndrome Post-viral Conjunctivitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Miller Fisher syndrome (MFS) is an uncommon variant of Guillain-Barré syndrome, typically identified by the presence of ophthalmoplegia, ataxia, and areflexia. While most cases follow this clinical pattern, atypical presentations lacking one or more components can complicate diagnosis. We report the case of an 81-year-old male with well-controlled hypertension who presented with acute-onset horizontal diplopia two weeks after a self-limiting episode of viral conjunctivitis. Neurological examination revealed complete bilateral ophthalmoplegia with preserved pupillary reflexes and no other focal deficits. Brain imaging and CSF analysis were unremarkable, with no evidence of albuminocytologic dissociation. A comprehensive serologic and autoimmune workup was negative, except for markedly elevated anti-GQ1b IgG titers (>1:12,800). The patient was diagnosed with an atypical form of MFS and received a five-day course of IVIG, which led to complete symptom resolution within one week. This case underscores the importance of considering MFS even in the absence of its full clinical triad. Anti-GQ1b IgG seropositivity remains a key diagnostic marker, and early treatment with IVIG can result in rapid and complete recovery. Clinicians should maintain a high index of suspicion for atypical MFS presentations, especially in patients presenting with isolated cranial nerve findings following a viral illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.